014 United-Amedisys

Current Status

The Health Care Market Oversight (HCMO) program reviews health care business deals, like mergers and acquisitions, to make sure they won’t harm people and communities in Oregon. 

This transaction is currently undergoing comprehensive review. On May 24, 2024, OHA received complete responses to its information request. Responses are posted under "Filings and Submissions" below. The review period is no longer paused.

Reports

• Determination Letter
• Preliminary Review Report
  
• Transaction Summary
  

Filings and Submissions

• Notice of Material Change Transaction
• Appendix A: Answers to HCMO Notice
• Appendix B: Provider identifiers and addresses
• Appendix C: Home health and hospice locations
  
• Appendix D: Merger Agreement
• Appendix F: February 2, 2024 Supplemental Responses
  
• May 17, 2024 Response to OHA Request for Information
• Redaction log (updated May 20, 2024)
  

One Page Transaction Summary

Public Comments

OHA is accepting public comments throughout the review period. To submit a public comment about this transaction, please email hcmo.info@oha.oregon.gov and include the word "Amedisys" in the subject line of your message.

• Compiled Email Public Comments 
  
• Public Comment from John Santa
  

Contact Us

Please email: hcmo.info@oha.oregon.gov

Media inquiries:
Erica Heartquist, Communications
erica.j.heartquist@oha.oregon.gov
(503) 871-8843